These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8118284)
21. Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer. Gitsch G; Kainz C; Joura E; Fröhlich B; Bieglmayr C; Tatra G Anticancer Res; 1992; 12(4):1247-9. PubMed ID: 1503417 [TBL] [Abstract][Full Text] [Related]
22. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix]. Ma SK; Wu LY; Sun YC; Li B; Zhang HT Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925 [TBL] [Abstract][Full Text] [Related]
23. Cancer of the uterine cervix: clinical value of squamous cell carcinoma antigen (SCC) measurements. Lozza L; Merola M; Fontanelli R; Stefanon B; Seregni E; Bombardieri E; De Palo G Anticancer Res; 1997; 17(1B):525-9. PubMed ID: 9066575 [TBL] [Abstract][Full Text] [Related]
24. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer. Davelaar EM; van de Lande J; von Mensdorff-Pouilly S; Blankenstein MA; Verheijen RH; Kenemans P Tumour Biol; 2008; 29(1):9-17. PubMed ID: 18497544 [TBL] [Abstract][Full Text] [Related]
25. The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix. Nakamura K; Okumura Y; Kodama J; Hongo A; Kanazawa S; Hiramatsu Y Gynecol Oncol; 2010 Oct; 119(1):81-6. PubMed ID: 20580064 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix. Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143 [TBL] [Abstract][Full Text] [Related]
28. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix]. Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418 [TBL] [Abstract][Full Text] [Related]
29. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix. Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of the uterine cervix]. Taïeb S; Ceugnart L; Leblanc E; Castelain B; Chevalier A JBR-BTR; 2003; 86(1):25. PubMed ID: 12807072 [No Abstract] [Full Text] [Related]
32. [Squamous cell carcinoma markers in neoplasms of the uterine cervix]. Freitag P; Fait T; Bendová M; Kostírová M; Zivný J Ceska Gynekol; 1998 Jun; 63(3):211-3. PubMed ID: 9750383 [No Abstract] [Full Text] [Related]
33. [Prognostic factors of uterine cervical cancer]. Yamakawa H; Konno R; Enomoto A; Netsu S; Takahashi S; Owada M; Suzuki M Gan To Kagaku Ryoho; 2006 Dec; 33(13):2002-7. PubMed ID: 17197743 [TBL] [Abstract][Full Text] [Related]
34. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET. Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level. Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631 [TBL] [Abstract][Full Text] [Related]
36. [The clinical usefulness of SCC antigen for diagnosis of recurrent cervical squamous cancer]. Umezawa S; Takeshima N; Shimizu Y; Hasumi K Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):165-8. PubMed ID: 7706858 [No Abstract] [Full Text] [Related]
37. [Squamous cell carcinoma (SCC)--nature and usage in patients with cervical carcinoma]. Bocheva Y; Bochev P; Chaushev B; Ivanov S Akush Ginekol (Sofiia); 2015; 54(2):29-34. PubMed ID: 25909138 [TBL] [Abstract][Full Text] [Related]
38. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix. Gocze PM; Vahrson HW; Freeman DA Oncology; 1994; 51(5):430-4. PubMed ID: 8052484 [TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness. Forni F; Ferrandina G; Deodato F; Macchia G; Morganti AG; Smaniotto D; Luzi S; D'Agostino G; Valentini V; Cellini N; Giardina B; Scambia G Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1145-9. PubMed ID: 17689030 [TBL] [Abstract][Full Text] [Related]
40. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen. Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]